Ariana Pharma

Absorption Systems, a Pharmaron company, is a full-service nonclinical CRO developing innovative services and solutions for the pharmaceutical, biotech, medical device and regenerative medicine industry. Our services include research and testing for small molecules, large molecules, biologics, medical device and cell and gene therapy products. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated outcomes when they occur. The company's facilities are strategically located in Philadelphia, San Diego, and Boston, servicing hundreds of customers throughout the world. Our focus is to maintain accuracy, timelines, and reliability at every stage of development. For more information on the company's comprehensive contract services and applied research programs, please visit absorption.com.

Accutest, a global independent and internationally accredited Contract Research Organisation (“CRO”), with more than 20 years of experience and over 700+ employees in supporting the end-to-end services for global bio-pharmaceutical, biotech, medical device, nutraceutical and FMCG companies. Accutest is the market leader among independent CROs, with the highest quality standards and quick turnaround times. We have a strong regulatory track record and numerous accreditation/approvals from global regulatory agencies.

We offer services in 3 verticals:
1. Bio-availability and Bio-equivalence studies (BA/BE) -
2. Clinical Development Services (CDS)- Phase II - IV studies, Post marketing, Investigator initiated & stand alone services (medical writing, regulatory consultancy, clinical data management)
3. Biologics Services - Solutions for biosimilars, novel biologics and non-biological complex generics

Successfully cleared below inspections:
USFDA – 33 times (latest Nov, 2018)
WHO – 23 times (latest Jan, 2019)
DCGI- 20 times (latest Oct, 2016)
EMA – 8 times (latest Dec, 2017)

Alpha Genesis® Inc. (AGI) provides the highest quality nonhuman primate products and bio-research services world-wide, with a customer base that extends across North America, Europe, and Asia. The Alpha Genesis Primate Research Center is a full-service facility that offers Nonhuman Primates for Biomedical Research, Contract Research and Consultation, Primate Housing and CDC Quarantine, and Biological Products and Materials. AGI maintains 100+ acres of primate breeding and holding facilities, and our large inventory of monkeys allows us to best serve your primate research needs. All AGI monkeys are of optimal health and are readily accessible for immediate availability and use. Individual monkey health records available to prospective clients upon request.

Principal research areas currently include: Aging and Metabolic Diseases, Immunogenetics and Immonology, Reproduction, Neurobiology, Physiological Ethology, Psychobiology. Recent research focus: embryonic stem cells, AIDS vaccine research, women's health, developmental disorders, glaucoma and presbyopia, osteoporosis, Parkinson's, movement disorders, diabetes, drug addiction, and obesity.

Veterinary training is available in primate biology, medicine, biomedical research, and behavior. Unique opportunity to work directly with monkeys. Educational opportunities are available to students case-by-case. Interested students should submit a research plan to info@alphagenesisinc.com. Outreach activities are also considered.

Since its inception AGI has grown to serve a broader customer base as we have strengthened our dedication to providing the very best and most cost-effective research and development support to the scientific community. Each AGI employee that works within our AAALAC accredited facilities is highly qualified and carefully trained specifically to complete the job you hired us to do.

If you have questions or would like to place an order, please e-mail AGI at info@alphagenesisinc.com or call toll-free 866.789.MONK (6665). Visit us on the web at www.alphagenesisinc.com or at www.primateresearch.com

Anapharm Bioanalytics is a customer-focused bioanalytical CRO specialized in small and large molecule bioanalysis. Led by a team with over 30 years’ experience in method development, validation and sample analysis, we support drug development programs for the pharmaceutical, biotechnological and generic industries worldwide.

Equipped with state-of-the-art LC-MS/MS and LBA technology platforms, Anapharm Bioanalytics provides an array of services including PK studies, biomarker testing and immunogenicity assays throughout preclinical and clinical stages. Our global network of partners allows us to provide full-service outsourcing solutions to conduct preclinical, Phase I-IV clinical trials, and bioequivalence studies for international registration.

Our clients benefit from a deep scientific expertise combined with a robust quality system. All our activities are compliant with GLP and GCP, having undergone 20 regulatory inspections by the FDA, several EU Health Authorities and ANVISA (Brazil).

Whether your drug candidate is a new chemical entity, a new biologic, a generic or a biosimilar, do not hesitate to contact us at info@anapharmbioanalytics.com.

This channel is intended only for US and Canadian visitors. The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada. An unaffiliated and unrelated company, Merck & Co. holds the rights in the trademark MERCK in the US and Canada.

Bringing pharma and biopharma healthcare solutions to life is complex, requiring specialist knowledge and expertise at every step.

This is why MilliporeSigma offers the BioReliance® portfolio – an offering of exceptional, risk-mitigating approaches, testing, critical services and customized, complete solutions to help you bring life-changing drugs to market, faster. We are a leading GMP and GLP testing services provider for the development of your therapeutics. Regulatory bodies such as the US Food & Drug Administrators (FDA) and the Medicines and Healthcare products Regulatory Agency (MHRA) require products to be tested for compliance before release. With locations worldwide, we offers more than 1,000 tests and complementary services related to biologics safety testing and specialized toxicology. For more information, visit www.bioreliance.com.